Earlier diagnosis and treatment of symptomatic bowel cancer: Can it be achieved and how much will it improve survival?

Colorectal Disease

Volumn 13, Issue 1, 2011, Pages 6-16

  Thompson, M R ^a   Heath, I ^b   Swarbrick, E T ^c   Faulds Wood, L ^d   Ellis, B G ^e  

^a QUEEN ALEXANDRA HOSPITAL   (United Kingdom)

^b Caversham Group Practice   (United Kingdom)

^c NEW CROSS HOSPITAL   (United Kingdom)

^d Lynn's Bowel Cancer Campaign ^*  (United Kingdom)

^e Swan Surgery   (United Kingdom)

Author keywords

Bowel cancer; Earlier diagnosis; Symptomatic disease

Indexed keywords

CANCER DIAGNOSIS; CANCER SURVIVAL; DELAYED DIAGNOSIS; DISEASE SEVERITY; EARLY DIAGNOSIS; EVIDENCE BASED MEDICINE; GENERAL PRACTITIONER; HUMAN; INTESTINE CANCER; OBSERVATIONAL STUDY; PATIENT REFERRAL; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; THEORETICAL MODEL; THERAPY DELAY;

EARLY DIAGNOSIS; GREAT BRITAIN; HUMANS; INTESTINAL NEOPLASMS; QUALITY OF HEALTH CARE; REFERRAL AND CONSULTATION; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; WAITING LISTS;

EID: 78650470052     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2009.01986.x     Document Type: Review

References (131)

1. Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, James PD, Mangham CM. Randomised control trial of faecal occult blood screening for colorectal cancer. Lancet 1996; 348: 1472-7.
2. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sandegaard O. Randomised study of screening for colorectal cancer with faecal occult blood test. Lancet 1996; 348: 1467-71.
3. Mandel J, Church T, Ederer F, Bond J. Colorectal cancer mortality: effectiveness of biennial screening for faecal occult blood. J Natl Cancer Inst 1999; 91: 434-7.
4. Jorgensen OD, Kronborg O, Fenger C. A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds. Gut 2002; 50: 29-32.
5. Feinstein AR. Symptoms as an index of biological behaviour and prognosis in human cancer. Nature 1966; 209: 241-5. (Level 2).
6. Dent OF, Chapuis PH, Goulston KJ. Relationship of survival to stage of the tumour and duration of symptoms in colorectal cancer. Med J Aust 1983; 19: 274-5.
7. Great Britain; Department of Health (2002). Referral Guidelines for Bowel Cancer. (accessed August 2009).
8. Cochrane AL. (1972) The Rock Carling Fellowship 1971. Effectiveness and efficiency. Random reflections on the health services. Burgess and Son, Abingdon.
9. York Health Economics Consortium (2007). Bowel Cancer Services: Costs and Benefits: Final Report to the Department of Health. (accessed August 2009).
10. Thompson MR. Referral Guidelines for colorectal cancer. Colorectal Dis 2002; 4: 287-97.
11. Great Britain; Department of Health (2002). Referral Guidelines for Bowel Cancer. (accessed August 2009).
12. Hayward RS, Laupacis A. Initiating, conducting and maintaining guidelines development programmes. CMAJ 1993; 148: 507-12.
13. Carruthers SG, Larochelle P, Haynes RB, Petrasovits A, Schriffin EI. Report of the Canadian Hypertension Society consensus conference: 1. Introduction. CMAJ 1993; 149: 289-93.
14. Cook DJ, Guyatt GH, Laupacis A, Sackett DL, Goldberg RJ. Clinical recommendations using levels of evidence for antithrombotic agents. Chest 1995; 108: 277-308.
15. Meltzer S, Leiter L, Daneman D, Gerstein HC, Lau D, Ludwig S, Yale JF, Zinman B, Lillie D. Clinical practice guidelines for the management of diabetes in Canada. CMAJ 1998; 150(Suppl. 8): 51-3.
16. Great Britain: Department of Health (1997) The New NHS - Modern, Dependable. The Stationery Office, London. (Command paper Cm3807).
17. Association of Coloproctology of Great Britain and Ireland (2007) Guidelines for the Management of Colorectal Cancer, 3rd edition. (accessed August 2009).
18. McSherry CK, Cornell GN, Glenn F. Carcinoma of the colon and rectum. Ann Surg 1969; 169: 502-9.
19. Wessex Colorectal Cancer Audit. 1990-1993.
20. Korsgaard M. (2005) Diagnostic Delay, Symptoms, and Stage of Colorectal Cancer: Population-based Observational Studies in Denmark. PhD Thesis. University of Aarhus, Aarhus.
21. Welch CE, Burke JF. Carcinoma of the colon and rectum. N Engl J Med 1962; 266: 211-9.
22. Tamoney HJ Jr, Caldarelli RA. Cancer of the right colon. An analysis of 211 patients. Dis Colon Rectum 1966; 9: 13-9.
23. Copeland EM, Miller LD, Jones RS. Prognostic Factors in Carcinoma of the Colon and Rectum. Am J Surg 1968; 116: 875-81. (Level 4).
24. Holliday HW, Hardcastle JD. Delay in diagnosis and treatment of symptomatic colorectal cancer. Lancet 1979; 1(8111): 309-11. (Level 3).
25. Ratcliffe R, Kiff RS, Kingston RD, Walsh SH, Jeacock J. Early diagnosis in colorectal cancer. Still no benefit? J R Coll Surg Edinb 1989; 34: 152-5. (Level 3).
26. Wheeler DW, Wakefield SE, Mortensen NJMcC, Kettlewell MGW. Delays experienced by patients with symptomatic colorectal cancer. Colorectal Dis 1999; 1: 174-6. (Level 3).
27. Olson L, Bergkvist L, Ekbom A. Symptom duration versus survival in non-emergency colorectal cancer. Scand J Gastroenterol 2004; 39: 252-8. (Level 3).
28. Bharucha S, Hughes S, Kenyon V, Anderson ID, Carlson GL, Scott NA. Targets and elective colorectal cancer: outcome and symptoms delay at surgical resection. Colorectal Dis 2005; 7: 169-71. (Level 4).
29. McDermott FT, Hughes ESR, Pihl E, Milnes BJ, Price AB. Prognosis in relation to symptom duration in colon cancer. Br J Surg 1981; 68: 846-9. (Level 3).
30. Barillari P, de Angelis R, Valabrega S, Indinnimeo M, Gozzo P, Ramacciato G, Fegiz G. Relationship of symptom duration and survival in patients with colorectal carcinoma. Euro J Surg Oncol 1989; 15: 441-5. (Level 4).
31. McDermott FT, Hughes ESR, Pihl E, Milne BJ, Price AB. Symptom duration and survival prospects in carcinoma of the rectum. Surg Gyn Obst 1981; 153: 321-6. (Level 5).
32. Clarke AM, Jones ISC. Diagnostic accuracy and diagnostic delay in carcinoma of the large bowel. N Z Med J 1970; 71: 341-7. (Level 4).
33. Irvin TT, Greaney MG. Duration of symptoms and prognosis of carcinoma of the colon and rectum. Surg Gyn Obst 1977; 144: 883-6. (Level 5).
34. Jolly KD, Scott JP, MacKinnon MJ, Clarke AM. Diagnosis and survival in carcinoma of the large bowel. Aust N Z J Surg 1982; 52: 12-6. (Level 4).
35. Turnbull PRG, Isbister WH. Colorectal cancer in New Zealand: a Wellington study. Aust N Z J Surg 1979; 49: 45-8.
36. Bassett ML, Bennett SA, Goulston KJ. Colorectal cancer. A study of 230 patients. Med J Aust 1979; 1: 589-92.
37. Schillaci A, Cavallaro A, Nicolanti V, Ferri M, Gallo P, Stipa S. The importance of symptom duration in relation to prognosis of carcinoma of the large intestine. Surg Gyn Obst 1984; 158: 423-6. (Level 4).
38. Khubchandani M. Relationship of symptom duration and survival in patients and carcinoma of the colon and rectum. Dis Colon Rectum 1985; 28: 585-7. (Level 5).
39. Polissar L, Sim D, Phil M, Francis A. Survival of colorectal cancer patients in relation to duration of symptoms and other prognostic factors. Dis Colon Rectum 1981; 24: 364-9. (Level 5).
40. Kyle SM, Isbister WH, Yeong ML. Presentation, duration of symptoms and staging of colorectal carcinoma. Aust N Z J Surg 1991; 61: 137-40. (Level 5).
41. Flashman K, O'Leary DP, Senapati A, Thompson MR. The Department of Health's 'two-week standard' for bowel cancer: is it working? Gut 2004; 53: 387-91.
42. Shekouh AR, Kent M, Hershamn MJ, Carter P, Rooney PS. The 'two week rule' (TWR) makes no difference to waiting times in colorectal cancer (CRC) treatment. Colorectal Dis 2001; 3(Suppl. 1): 41.
43. Eccersley AJ, Wilson EM, Makris A, Novell JR. Referral guidelines for colorectal cancer-do they work? Ann R Coll Surg Engl 2003; 85: 107-10.
44. MacArthur C, Smith A. Factors associated with speed of diagnosis, referral, and treatment in colorectal cancer. J Epidemiol Community Health 1984; 38: 122-6.
45. Roncoroni L, Pietra N, Violi V, Sarli L, Choua O, Peracchia A. Delay in the diagnosis and outcome of colorectal cancer: a prospective study. Eur J Surg Oncol 1999; 25: 173-8.
46. MacAdam DB. Delay in diagnosis of symptomatic colorectal cancer. Lancet 1979; 1: 489-90.
47. The National Collaborating Centre for Primary Care (2005) Referral Guidelines for Suspected Cancer in Adults and Children. Part 1. pp. 278-9. (accessed August 2009).
48. Turunen MJ, Peltokallio P. Delay in the diagnosis of colorectal cancer. Ann Chir Gynaecol 1982; 71: 227-82. (Level 5).
49. Mansson J. The diagnosis of colorectal cancer - experiences from the community of Kungsbacka, Sweden. Scand J Prim Health Care 1990; 8: 31-5.
50. Harris GJC, Simson JNL. Causes of late diagnosis in cases of colorectal cancer seen in a district general hospital over a 2-year period. Ann R Coll Surg Engl 1998; 80: 246-8.
51. Dixon AR, Thornton-Holmes J, Cheetham NM. General practitioners' awareness of colorectal cancer: a 10-year review. BMJ 1990; 301: 152-3.
52. Robertson R, Campbell NC, Smith S, Donnan PT, Sullivan F, Duffy , Ritchie LD, Millar D, Cassidy J, Munro A. Factors influencing time from presentation to treatment of colorectal and breast cancer in urban and rural areas. Br J Cancer 2004; 90: 1479-85.
53. Goodman D, Irvin TT. Delay in the diagnosis and prognosis of carcinoma of the right colon. Br J Surg 1993; 80: 1327-9. (Level 5).
54. Stebbing JF, Nash AG. Avoidable delay in the management of carcinoma of the right colon. Ann R Coll Surg Engl 1995; 77: 21-3.
55. Fegiz G, Barillari P, Ramacciato G, de Angelis R, Gozzo P, Indinnimeo M, Valabrega S. Right colon cancer: long-term results after curative surgery and prognostic significance of duration of symptoms. J Surg Oncol 1989; 41: 250-5.
56. Wright HK, Higgins EF. Natural history of occult right colon cancer. Am J Surg 1982; 143: 169-70.
57. Fagan PA. The "Red Herring" barium-meal x-ray examination in carcinoma of the right side of the colon. Med J Aust 1969; 1: 276-8.
58. Mohammed MA. (2002). Towards Improving Outcomes for Colorectal Cancer. PhD Thesis. University of Birmingham, Birmingham, UK.
59. Macdonald I. Biological pre-determinism in human cancer. Surg Gynecol Obstet 1951; 92: 443-52.
60. Macdonald I. The individual basis of biologic variability in cancer. Surg Gynecol Obstet 1958; 106: 227-9.
61. Baig MK, Whatley P, Thompson MR Does early and prompt treatment of symptomatic cancer improve survival? Gut 1998;42(Suppl. 1): A93. (Abstract TF371) (Level 5).
62. Pack GT, Gallo JS. The culpability for delay in the treatment of cancer. Am J Cancer 1938; 33: 443-62.
63. Braund RR, Binkley GE. A plea for the earlier diagnosis of rectal cancer: an analysis of 108 clinic patients. N Y State J M 1942; 1: 33-7.
64. Thompson MR, Heath I, Ellis BG, Swarbrick ET, Faulds Wood L, Atkin WS. Identifying and managing patients at low risk of bowel cancer in general practice. BMJ 2003; 327: 263-5.
65. Thompson MR, Flashman KG, Wooldrage K, Rogers PA, Senapati A, O'Leary DP, Atkin W. Flexible sigmoidoscopy and whole colonic imaging in the diagnosis of cancer in patients with colorectal symptoms. BJS 2008; 95: 1140-6.
66. Sackett DL, Haynes RB, Guyatt GH, Tugwell P (1991) Clinical Epidemiology - A Basic Science for Clinical Medicine. 2nd edition. Chapter 5: pp. 155-156. Early Diagnosis. Little Brown and Co., Boston/Toronto/London.
67. Hutchinson GB. Evaluation of preventive services. J Chronic Dis 1960; 11: 497.
68. Spratt JS. The rates and patterns of growth of neoplasms of the large intestine and rectum. Surg Clin North Am 1965; 45: 1103-15.
69. Finlay IG, Meek D, Brunton F, McArdle CS. Growth rate of hepatic metastases in colorectal carcinoma. Br J Surg 1988; 75: 641-4.
70. Welin S, Youker J, Spratt JS Jr et al. The rates and patterns of growth of 375 tumours of the large intestine and rectum observed serially by double contrast enema study (Malmo Technique). Am J Roentgenol Radium Ther Nucl Med 1963; 90: 673-87.
71. Baig MK, Whatley P, Thompson MR. Delays during stage of referral, diagnosis and treatment of colorectal cancer: their relationship to mortality. Gut 1999; 44(Suppl. 1): T62.
72. Haggitt RC, Glotzbach RE, Soffer EE, Wruble LD. Prognostic factors in colorectal carcinomas arising in adenomas: implications for lesions removed by endoscopic polypectomy. Gastroenterology 1985; 89: 328-36.
73. Kikuchi R, Takano M, Takagi K, Fujimoto N, Nozaki R, Fujiyoshi T, Uchida Y. Management of early invasive colorectal cancer. Risk of recurrence and clinical guidelines. Dis Colon Rectum 1995; 38: 1286-95.
74. Ueno H, Mochizuki H, Hashiguchi Y. et al. Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology 2004; 127: 385-94.
75. Gatta G, Faivre J, Capocaccia R, Ponz de Leon M, EUROCARE Working Group. Survival of colorectal cancer patients in Europe during the period 1978-1989. Eur J Cancer 1998; 34: 2176-83.
76. National Cancer Institute (1998) National Cancer Institute SEER Stat - Cancer Incidence Public Use Database. 1973-95. Release 1.1. National Cancer Institute, Bethesda, MD.
77. Gatta G, Capocaccia R, Sant M et al. Understanding variations for colorectal cancer in Europe: a EUROCARE high resolution study. Gut 2000; 47: 533-8.
78. Ciccolallo L, Capocaccia R, Coleman MP. et al. Survival differences between European and US patients with colorectal cancer; role of stage at diagnosis and surgery. Gut 2005; 54: 268-73.
79. Wrigley H, Roderick P, George S, Smith J, Mullee M, Goddard J. Inequalities in survival from colorectal cancer: a comparison of the impact of deprivation, treatment, and hosts factors on observed and cause specific survival. J Epidemiol Community Health 2003; 57: 301-9.
80. Baig MK, Whatley P, Thompson MR. Wessex Colorectal Cancer Audit. The effect on survival of differences in case-mix between districts. Gut 1998; 42(Suppl. 1): T59.
81. Wessex Colorectal Cancer Audit. 1990-1993. South West Cancer Intelligence Unit.
82. Chapuis PH, Dent OF, Fisher R, Newland RC, Pheils MT, Smyth E, Colquhoun K. A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer. Br J Surg 1985; 72: 698-702. (Level 3).
83. Armstrong-James D, Moss S, Bygrave S, Thompson MR Colorectal cancer patients presenting with rectal bleeding have earlier stage tumours and longer pre-diagnosis history. Gut 1997;40(Suppl. 1):A50. (Abstract TH199) (Level 5).
84. Rafftery TL, Samson N. Carcinoma of the colon: a clinical correlation between presenting symptoms and survival. Am J Surg 1980; 46: 600-6.
85. Stapley S, Peters TJ, Sharp D, Hamilton W. The mortality of colorectal cancer in relation to the initial symptom at presentation to primary care and to the duration of symptoms: a cohort study using medical records. Br J Cancer 2006; 95: 1321-5.
86. Robinson E, Mohilever J, Zidan J, Sapir D. Colorectal cancer: incidence, delay in diagnosis and stage of disease. Eur J Clin Oncol 1986; 22: 157-61. (Level 5).
87. Rowe-Jones DC, Aylett SO. Delay in treatment in carcinoma of colon and rectum. Lancet 1965; 286: 973-6. (Level 5).
88. Arbman G, Nilsson E, Storgren-Fordell V, Sjodahl R. A short diagnostic delay is more important for rectal cancer than for colonic cancer. Eur J Surg 1996; 162: 899-904. Also Reference 92 (Level 3).
89. Keddie N, Hargreaves A. Symptoms of carcinoma of the colon and rectum. Lancet 1968; 2: 749-50. (Level 5).
90. MacLeod JH, Chipman ML, Gordon PC, Graham CH. Survivorship following treatment for cancer of the colon and rectum. Cancer 1970; 6: 1225-31. (Level 5).
91. Garcia OD, Pellicer FE, Cifuentes TJ, Morales CG, Estevan RE, Ortiz EMA, Parrilla PP. Colorectal cancer: are diagnostic delay, degree of spread and survival related? Clinical analysis of 307 cases followed up for more than 4 years. Rev Esp Enferm Apar Dig 1989; 76: 239-42. (Level 5).
92. Stower MJ, Hardcastle JD. The results of 1115 patients with colorectal cancer treated over an 8-year period in a single hospital. Eur J Surg Oncol 1985; 11: 119-23. (Level 3).
93. Garcia-Peche P, Vazquez-Prado A, Fabra-Ramis R, Trullenque-Peris R. Factors of prognostic value in long-term survival of colorectal cancer patients. Hepatogastroenterology 1991; 38: 438-43. (Level 5).
94. Waldron RP, Donovan IA, Drumm J, Mottram SN, Tedman S. Emergency presentation and mortality from colorectal cancer in the elderly. Br J Surg 1986; 73: 214-6. (Level 4).
95. Stubbs RS, Long MG. Symptom duration and pathologic staging of colorectal cancer. Euro J Surg Oncol 1986; 12: 127-30. (Level 5).
96. Nilsson E, Bolin S, Sjödahl R. Carcinoma of the colon and rectum. Delay in Diagnosis. Acta Chir Scand 1982; 148: 617-22. (Level 5).
97. Pescatori M, Maria G, Beltrani B, Mattana C. Site, emergency and duration of symptoms in the prognosis of colorectal cancer. Dis Colon Rectum 1982; 25: 33-40. (Level 5).
98. Mulcahy HE, O'Donoghue PE. Duration of colorectal cancer symptoms and survival; the effect of confounding clinical and pathological variables. Eur J Cancer 1997; 33: 1461-7. (Level 3).
99. Slaney G. (1971) Results of treatment of carcinoma of the colon and rectum. In: Modern Trends in Surgery 3 (ed. Irvine W), pp. 69-89. Butterworths Sevenoaks, Kent. (Level 4).
100. Ragland JJ, Londe AM, Spratt JS. Correlation of the prognosis of obstructing colorectal carcinoma with clinical and pathologic variables. Am J Surg 1971; 121: 552-6. (Level 3).
101. Baig MK, Whatley P, Thompson MR. Delay in diagnosis and treatment of colorectal cancer; Does it affect outcome? Gut 1999; 44(Suppl.): A143. (Abstract TH572) (Level 5).
102. Gonzalez-Hermoso F, Perez-Palma J, Marchena-Gomez J, Lorenzo-Rocha N, Medina-Arana V. Can early diagnosis of symptomatic colorectal cancer improve the prognosis?. World J Surg 2004; 28: 716-20.
103. Tsavellas G, Pond C, Thompson MR. Colorectal cancer patients with rectal bleeding have earlier stage disease and better outcomes. Colorectal Dis 2000; 2(Suppl. 1): 41.
104. Goulston KJ, Cook I, Dent OF, General Practitioners and Specialists Associated with the Concord Hospital Gastroenterology Unit. How important is rectal bleeding in the diagnosis of bowel cancer and polyps? Lancet 1986; 2: 261-5.
105. Metcalf JV, Smith J, Jones R, Record CO. Incidence and causes of rectal bleeding in general practice as detected by colonoscopy. Br J Gen Pract 1996; 46: 161-4.
106. Norreland N, Norreland H. Colorectal cancer and polyps in patients aged 40 years and over who consult a GP with rectal bleeding. Fam Pract 1996; 13: 160-5.
107. Chapuis PH, Goulston KJ, Dent OF, Tait AD. Predictive value of rectal bleeding in screening for rectal and sigmoid polyps. BMJ 1985; 290: 1546-8.
108. Fijten GH, Starmans R, Muris JWM, Schouten HJA, Blijham GH, Knottnerus JA. Predictive value of signs and symptoms for colorectal cancer in patients with rectal bleeding in general practice. Fam Pract 1995; 12: 279-86.
109. Ellis BG, Thompson MR. Factors identifying higher risk bleeding in general practice. Br J Gen Pract 2005; 55: 949-55.
110. Atkin WS, Cuzick J, Northover JM, Whynes DK. Prevention of colorectal cancer by once-only flexible sigmoidoscopy. Lancet 1993; 341: 736-40.
111. Retsas S. Early or low-grade melanoma? Lancet 1987; 2: 276-7.
112. Symonds RP. Cancer biology may be more important than diagnostic delay. BMJ 2002; 325: 774.
113. Retsas S, Henry K, MacKenzie DH. Missed malignant melanoma. BMJ 1986; 292: 1270-1.
114. Retsas S, Henry K, MacKenzie DH. Missed malignant melanoma. BMJ 1986; 293: 50-1.
115. Cassileth Br, Clark WH Jr, Heiberger RM, March V, Tenaglia A. Relationship between patients' early recognition of melanoma and depth of invasion. Cancer 1982; 49: 198-200.
116. Crawford SC, Davis JA, Siddiqui NA, De Caestecker L, Gillis CR, Hole D. The waiting paradox: population based retrospective study of treatment delay and survival of women with endometrial cancer in Scotland. BMJ 2002; 325: 196.
117. Symonds P, Bolger B, Hole D, Mao JH, Cooke T. Advanced-stage cervix cancer: rapid tumour growth rather than late diagnosis. Br J Cancer 2000; 83: 566-8.
118. Sainsbury R, Johnson C, Haward B. Effect on survival of delays in referral of patients with breast-cancer symptoms: a retrospective analysis. Lancet 1999; 353: 1132-5.
119. The UK CRC Screening Pilot Evaluation Team (2003). Evaluation of the UK Colorectal Cancer Screening Pilot: Final Report. Section 5. (accessed August 2009).
120. Young CJ, Sweeney JL, Hunter A. Implications of delayed diagnosis in colorectal cancer. N Z J Surg 2000; 70: 635-8.
121. Hackett TP, Cassem NH, Raker JW. Patient delay in cancer. N Eng Med J 1973; 289: 14-20.
122. MacAdam DB. A study in general practice of the symptoms and delay patterns in the diagnosis of gastrointestinal cancer. J Roy Coll Gen Pract 1979; 29: 723-9.
123. Curless R, French JM, Williams GV, James OFW. Colorectal carcinoma: do elderly patients present differently? Age Ageing 1994; 23: 102-7.
124. Harms CR, Plaut JA, Oughterson AW. Delay in the treatment of cancer. JAMA 1943; 121: 335-8.
125. Potter MA, Wilson RG. Diagnostic delay in colorectal cancer. J R Coll Surg Edinb 1999; 44: 313-6.
126. Springall RG, Todd IP. General practitioner referral of patients with lower gastrointestinal symptoms. J R Soc Med 1988; 81: 87-8.
127. Hennigan TW, Franks PJ, Hocken DB, Allen-Mersh TG. Rectal examination in general practice. BMJ 1990; 301: 478-80.
128. Rubin GP. Endoscopy facilities in general practice. BMJ 1992; 304: 1542-3.
129. Rex DK, Rahmani EY, Haseman JH, Lemmel GT, Kaster S, Buckley JS. Relative sensitivity of colonoscopy and barium enema for detection of colorectal cancer in clinical practice. Gastroenterology 1997; 112: 17-23.
130. Hosokawa O, Shirasaki S, Kaizaki Y, Hayashi H, Douden K, Hattori M. Invasive colorectal cancer detected up to 3 years after a colonoscopy negative for cancer. Endoscopy 2003; 35: 506-10.
131. Mor V, Masterson-Allen S, Goldberg R, Guadagnoli E, Wool MS. Pre-diagnostic symptom recognition and help seeking among cancer patients. J Community Health 1990; 15: 253-66.